GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lexaria Bioscience LEXX · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.54

+0.89%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Bunka (Christopher A)655.5k2.63%+27.5k9 Oct 2025
Docherty (John Martin)59.5k0.24%—9 Oct 2025
Christopher (Richard C)58.2k0.23%−6.8k9 Oct 2025
Wealth Enhancement Advisory Services, LLC35.8k0.14%+5k30 Sept 2025
Byrne Asset Management LLC31.3k0.13%−2.9k30 Sept 2025
McKechnie (William Edward)18.2k0.07%—9 Oct 2025
Bhullar (Baljinder)13k0.05%+13k9 Oct 2025
Baxter (Nicholas W)11k0.04%—9 Oct 2025
Reese (Albert L Jr)10.9k0.04%—9 Oct 2025
Carle (Vanessa)7500.00%+75029 Jul 2025
Farther Finance Advisors, LLC1660.00%—30 Sept 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

255.8k

-6.8% on the period before. 3.3 days to cover.

Short volume

Share of the day's trading sold short, 5 Nov 2026

60.3%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 25 Sept 2026599 shares
  • 23 Sept 20263,933 shares
  • 18 Sept 20267,550 shares
  • 17 Sept 2026211 shares
  • 8 Sept 2026100 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.